Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Technical Analysis on One NASDAQ-Listed Biotechnology Stock - GILD

Jul 29, 2026 | Team Kalkine
Technical Analysis on One NASDAQ-Listed Biotechnology Stock - GILD
Image source: Shutterstock

Gilead Sciences, Inc. (NASDAQ: GILD) 

Gilead Sciences, Inc. (NASDAQ: GILD) develops and commercializes treatments for life-threatening infectious diseases, focusing on the Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular diseases. With headquarters in Foster City, California, GILD has a global presence in over 35 countries.

Technical Observation (on the daily chart)


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…